Cui YY - Search Results

1

[Clinical features of patients with metastatic pheochromocytoma/paraganglioma].

Cui YY, Zhou Y, Gao YJ, Li TY, Wang Y, Zhang WQ, Zhou T, Chen S, Tong AL. Cui YY, et al. Zhonghua Yi Xue Za Zhi. 2024 Apr 9;104(14):1174-1179. doi: 10.3760/cma.j.cn112137-20230820-00271. Zhonghua Yi Xue Za Zhi. 2024. PMID: 38583049 Chinese.

2

[Studies on metabolism of 6-chloro butyl phthalide by rat liver microsomes].

Peng SH, Cui YY, Zhou TH. Peng SH, et al. Among authors: cui yy. Yao Xue Xue Bao. 1996;31(6):466-71. Yao Xue Xue Bao. 1996. PMID: 9275725 Chinese.

3

[Studies on metabolism of 6-methoxy butyl phthalide by rat liver microsomes].

Peng SH, Cui YY, Zhou TH. Peng SH, et al. Among authors: cui yy. Yao Xue Xue Bao. 1996;31(7):539-42. Yao Xue Xue Bao. 1996. PMID: 9772697 Chinese.

4

[The in vitro metabolism of hainanensine derivative HH07A by rat liver microsomes].

Zhang WJ, Zhou TH, Cui YY. Zhang WJ, et al. Among authors: cui yy. Yao Xue Xue Bao. 1997;32(2):116-20. Yao Xue Xue Bao. 1997. PMID: 11243194 Chinese.

5

Diagnostic Value of Urinary MicroRNAs for Bladder Cancer in Asia.

Cui Y, Zhou T. Cui Y, et al. J Coll Physicians Surg Pak. 2021 Oct;31(10):1207-1213. doi: 10.29271/jcpsp.2021.10.1207. J Coll Physicians Surg Pak. 2021. PMID: 34601843

6

[Recurrence and metastasis of pheochromocytoma/paraganglioma after tumor resection and clinical characteristics analysis].

Gao YJ, Cui YY, Ma XS, Wang HP, Liu J, Lou FC, Zhou T, Chen S, Lu L, Tong AL. Gao YJ, et al. Among authors: cui yy. Zhonghua Yi Xue Za Zhi. 2022 Mar 15;102(10):729-734. doi: 10.3760/cma.j.cn112137-20210802-01713. Zhonghua Yi Xue Za Zhi. 2022. PMID: 35280017 Chinese.

7

Cluster analysis of antiphospholipid antibodies-associated adverse pregnancy outcome patients: based on a 13-years cohort study.

Long Y, Huang C, Cui Y, Xie Z, Zhou Y, Shi X, Song Y, Tian X, Li M, Liu J, Liu X, Zeng X, Zhao J. Long Y, et al. Clin Exp Med. 2023 Dec;23(8):5377-5388. doi: 10.1007/s10238-023-01195-x. Epub 2023 Oct 11. Clin Exp Med. 2023. PMID: 37821708

8

Novel alternative tools for metastatic pheochromocytomas/paragangliomas prediction.

Cui Y, Zhou Y, Gao Y, Ma X, Wang Y, Zhang X, Zhou T, Chen S, Lu L, Zhang Y, Chang X, Tong A, Li Y. Cui Y, et al. J Endocrinol Invest. 2024 May;47(5):1191-1203. doi: 10.1007/s40618-023-02239-5. Epub 2024 Jan 11. J Endocrinol Invest. 2024. PMID: 38206552 Clinical Trial.

9

A novel strategy for predicting the efficacy of temozolomide treatment for metastatic pheochromocytomas/paragangliomas.

Cui Y, Gao Y, Zhou Y, Ma X, Wang Y, Zhou T, Wen J, Chen S, Lu L, Tong A, Li Y. Cui Y, et al. J Endocrinol Invest. 2024 Dec;47(12):3039-3048. doi: 10.1007/s40618-024-02398-z. Epub 2024 Jun 5. J Endocrinol Invest. 2024. PMID: 38837102

10

[The relationship between clinical characteristics and pathological features in patients with pheochromocytomas/paragangliomas].

Zhou Y, Zhang WQ, Chen YH, Cui YY, Wang Y, Li TY, Chang XY, Tong AL. Zhou Y, et al. Among authors: cui yy. Zhonghua Yi Xue Za Zhi. 2024 Jul 23;104(28):2613-2618. doi: 10.3760/cma.j.cn112137-20231218-01404. Zhonghua Yi Xue Za Zhi. 2024. PMID: 39019817 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

264 results

Search Page

Filters